clevidipine has been researched along with propofol in 3 studies
| Studies (clevidipine) | Trials (clevidipine) | Recent Studies (post-2010) (clevidipine) | Studies (propofol) | Trials (propofol) | Recent Studies (post-2010) (propofol) |
|---|---|---|---|---|---|
| 127 | 19 | 62 | 16,827 | 5,188 | 6,805 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Lombardo, F; Obach, RS; Waters, NJ | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Dotson, B; Tennenberg, SD | 1 |
1 review(s) available for clevidipine and propofol
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
2 other study(ies) available for clevidipine and propofol
| Article | Year |
|---|---|
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
Parenteral nutrition in the critically ill patient.
Topics: Calcium Channel Blockers; Critical Illness; Energy Intake; Fat Emulsions, Intravenous; Humans; Hypnotics and Sedatives; Parenteral Nutrition; Propofol; Pyridines | 2010 |